Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti-PD-1 resistance.
J Clin Invest
; 133(21)2023 11 01.
Article
in En
| MEDLINE
| ID: mdl-37651197
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myeloid-Derived Suppressor Cells
/
Melanoma
Limits:
Animals
/
Humans
Language:
En
Journal:
J Clin Invest
Year:
2023
Document type:
Article
Affiliation country: